Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Global Antibody Market Expected to Reach USD 318,482.1 Million by 2027, With a CAGR Of 10.1% | Growth Market Reports | ||
| By: PR Newswire Association LLC. - 23 Jul 2021 | Back to overview list |
|
|
PUNE, India, July 23, 2021 /PRNewswire/ -- According to a recent market study published by Growth Market Reports, titled, "Global Antibody Market by Types, (Monoclonal Antibodies, Polyclonal Antibodies, ADCs, And Others) by Technology, (Western Blotting, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, And Others), by Applications (Proteomics, Drug Development, and Genomics), By End-users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and CROs), and by Regions : Size, Share, Trends and Opportunity Analysis, 2018-2028", the market was valued at USD 147,431.4 Million in 2019 and is expected to grow at a healthy growth rate of 10.1% by the year 2027. The global antibody market is anticipated to grow significantly during forecast period. The demand for antibodies is growing due to increasing demand of fast recovery, growing number of patients with diabetic and cardiovascular disorders, and rising number of research and development activities.  Key Market Players Profiled in the Report
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis. Download PDF Sample here: https://growthmarketreports.com/request-sample/1290 This report also includes a complete analysis of industry players that cover their latest developments, product portfolio, pricing, mergers, acquisitions, and collaborations. Moreover, it provides crucial strategies that are helping them to expand their market share. Highlights on the segments of the Antibody Market Based on types, the global antibody market is divided into monoclonal antibodies, polyclonal antibodies, ADCs, and others. Their use in the treatment of illnesses such as coronavirus, monoclonal antibodies are expected to have a large share of the market over the forecast period. Increase in cancer patients throughout the world, ADCs used to treat malignant tumours are rapidly growing popularity. Monoclonal antibody drugs are expensive to manufacture, but they are widely available in the market, making them accessible to customers, which drives the market. Polyclonal antibodies are predicted to proliferate rapidly due to their ability to bind many antigen epitopes. In terms of technology, the global antibody market is classified into western blotting, flow cytometry, ELISA, immunohistochemistry, immunofluorescence, immunoprecipitation, and others. Owing to the precision, the western blotting segment is expected to occupy a considerable proportion of the market over the projection period. Antibodies to HIV were detected as a consequence of the tests. Flow cytometry is thought to be rapidly expanding since it can do multi-parameter analysis on single cells inside a sample combination that is heterogeneous. In terms of applications, the global antibody market is classified into proteomics, drug development, and genomics. Owing to the efficient mapping of drug-protein and protein-protein interactions, the proteomics sector is expected to occupy a major proportion of the market over the projected period. The drug development segment is expected to expand rapidly, since it facilitates the release of sophisticated drugs and vaccines following FDA clearance. Attributing to advancements in genetic research of an organism and chances for cancer patients using stem cell treatment, the genomics segment is predicted to increase at a significant rate. Based on end-users, the global antibody market is classified as pharmaceutical and biotechnology companies, academic and research institutes, and CROs. The introduction of medicines and vaccines for horrible illnesses, pharmaceutical and biotechnology firms are expected to have a large proportion of the market throughout the predicted period. CROs are expected to increase at a high rate, since they assist clinical studies of newly marketed vaccines and medications prior to market release. As a comprehensive study of illnesses is completed and a deep understanding of antigen is supplied, the academic and research institutions segment is predicted to increase at a quick rate. Based on regions, the global antibody market is fragmented into North America, Europe, Latin America, and Middle East & Africa. North America accounted for a significant share of the market in 2019. During the projected period, the market in Latin America, the Middle East and Africa, and Europe is expected to grow at a considerable CAGR. During the forecast period, North America is expected to have the greatest share. Stem cell treatment research and technological improvements are offering attractive prospects for participants in this field. Due to the increased frequency of chronic illnesses such as cardiovascular and blood illnesses, Europe is likely to occupy a significant market share. Due to research and development initiatives, Asia Pacific is a potential area for the antibody market. The collaboration of several medical institutes and academic institutions is expected to improve the situation. To Buy the Complete Report: https://growthmarketreports.com/report/antibody-market-global-industry-analysis Key Takeaways from the Study:
Read 261 Pages Research Report with Detailed ToC on "Global Antibody Market by Types, (Monoclonal Antibodies, Polyclonal Antibodies, ADCs, And Others) by Technology, (Western Blotting, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, And Others), by Applications (Proteomics, Drug Development, and Genomics), By End-users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and CROs), and by Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028" For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/1290 Key Segments Covered By Type
By Technology
By Applications
By End-users
By Regions
Other Trending Reports:
About Growth Market Reports: Growth Market Reports provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Industry Intelligence Solutions". Growth Market Reports has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, and secondary research & consumer surveys. Contact: Alex Mathews
SOURCE Growth Market Reports 
|
||
|
|
||
 | Back to overview list | |
View original content: